Main container

BTM and BIOBank sign an agreement protocol

To develop research and innovation in the preservation of human tissues

20 October 2022

Wednesday, October 19 took place an official meeting with the Director of the Bank of Musculoskeletal Tissue (BTM) Dante Dallari and the General Director of the Rizzoli Orthopaedic Institute Anselmo Campagna, together with the BTM Research and Development team, and BIOBank President Patrick Joucla and his team to sign an important agreement to develop research and innovation in the field of the conservation of human tissues.

I team BTM e BIOBank in occasione della firma dell'accordo. Al centro il Direttore Generale del Rizzoli Anselmo Campagna e il Presidente di BIOBank Patrick Joucla
The BTM and BIOBank teams during of the signing of the agreement. At the center the General Director of Rizzoli Anselmo Campagna and the President of BIOBank Patrick Joucla

The BIOBank company was founded as an independent firm and Tissue Bank for: orthopedic, spinal, dental and maxillofacial surgery. The BIOBank, located near Paris, is leader in the field for over 20 years and is the first French bank specialized in bone grafts with the ISO 13485 certification that guarantees a quality management system that complies with standards and requirements on medical devices, which has allowed its development at European and international level.

The BIOBank, certified as a tissue bank by ANSM (French National Safety Agency for Health Products), is authorized to: supply, store, process and bankroll bone grafts.

The strong point of BIOBank processing is a machine that allows the treatment of bone grafts with CO2 in the supercritical state that guarantees a more accurate cleaning of the bone.

Log in to download the price list, forms and technical sheets

Reserved Area